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Down syndrome (DS), caused by a trisomy 21, is the most common chromosomal aneuploidy 
occurring in approximately 1 of 750 live births. Individuals with DS exhibit craniofacial 
dysmorphology, cardiac defects, gastrointestinal problems, and cognitive impairment, although 
these phenotypes vary in incidence and severity. Common cardiac defects are usually recognized 
in young infants with DS and include atrial septal anomalies, ventricular septal abnormalities, 
atrioventricular canal defects, and patent ductus arteriosus. Additional abnormalities may also 
affect infants with DS, but not be identified until later in life. Since multiple phenotypes are 
found in these individuals, we hypothesize that children with a severe congenital heart defect 
may be at increased risk for additional medical issues. To investigate this hypothesis, we 
performed a retrospective chart review of 170 infants with DS between birth and 6 months of age 
who were referred to the Down Syndrome Program at Riley Hospital for Children from August 
2005 to July 2010. We analyzed comorbidity in infants with upper airway obstruction (UAO) or 
a feeding problem with and without a severe congenital heart defect. Our data show that 33% of 
infants without a cardiac defect have identified UAO while 44% with a severe cardiac defect 
have identified UAO. Additionally, 59% of infants without a cardiac defect compared to 49% 
with a severe cardiac defect have a feeding problem. With the knowledge of these comorbid 
clinical features in DS, healthcare providers may be able to identify potential complications 
affecting infants with DS earlier in life. 
